Alteogen Postpones KOSPI Transfer, Remains on KOSDAQ
Alteogen, the top market capitalization biotech company on KOSDAQ, postponed its planned transfer to KOSPI through a board resolution disclosed on the 16th. The company determined that remaining on KOSDAQ better aligns with enhancing corporate value and maximizing shareholder interests after
LucasBennett·07-22 07:45
